Project Details
Description
Phase 1 Safety and Tolerability Study of Figitumumab combined with Pegvisomant in Patients with Advanced Solid Tumors
Status | Finished |
---|---|
Effective start/end date | 5/1/09 → 5/31/15 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.